Gossamer Bio, Inc. - Common Stock (GOSS)

Gossamer Bio Inc is a biotechnology company focused on discovering and developing innovative medicines to address significant unmet medical needs in various therapeutic areas, including immunology and oncology

The company employs a data-driven approach to identify and advance potential drug candidates through preclinical and clinical stages of development. By leveraging cutting-edge science and technology, Gossamer Bio aims to create targeted treatments that improve patient outcomes and quality of life in complex diseases.